echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Infection > GenScript neutralizing antibody test kit enters the Middle East market for the first time and will be used to evaluate the effectiveness of the new crown vaccine

    GenScript neutralizing antibody test kit enters the Middle East market for the first time and will be used to evaluate the effectiveness of the new crown vaccine

    • Last Update: 2021-03-30
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Recently, the world's leading biotechnology company GenScript (stock code: 1548.


    GenScript's cPass SARS-CoV-2 neutralizing antibody test kit is widely used in 24 regions throughout the Middle East and North Africa to evaluate the effectiveness of the new coronary pneumonia vaccine.


    This serum kit called cPass sVNT Kit is the world’s first kit that can quickly and effectively detect functional neutralizing antibodies developed by Duke-National University of Singapore School of Medicine.


    It is reported that neutralizing antibodies can inhibit virus infection and spread by preventing the virus from binding to specific receptors of host cells, and become the first line of defense against SARS CoV-2 infection.


    Since its launch, cPass sVNT Kit has been highly regarded in the international market for its advantages of simplicity, speed, convenience and effectiveness.


    It is reported that in February 2021, GenScript has reached a cooperation agreement with Nine Strong Biotech and Sinopharm Investment (a member company of Sinopharm Group) on the promotion of its commercial application in China, in order to better utilize the advantages of all parties and make this efficient Testing services will be promoted to the front line as soon as possible, benefiting more people, and contributing to China's anti-epidemic cause.


    Dr.


    Johnson Wang, President of GenScript Asia Pacific, said: "We are very pleased to cooperate with G42 Healthcare to provide innovative solutions to help people in the UAE and more regions.


    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.